CONTOUR NEUROVASCULAR SYSTEM

Serial Number 88344703
Registration 6583936
700

Registration Progress

Application Filed
Mar 18, 2019
Under Examination
Apr 7, 2020
Approved for Publication
Feb 11, 2020
Published for Opposition
Feb 11, 2020
Registered
Dec 7, 2021

Trademark Image

CONTOUR NEUROVASCULAR SYSTEM

Basic Information

Serial Number
88344703
Registration Number
6583936
Filing Date
March 18, 2019
Registration Date
December 7, 2021
Published for Opposition
February 11, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 7, 2021
Registration
Registered
Classes
010

Rights Holder

STRYKER IRELAND TECHNOLOGY LTD.

16
Address
IDA BUSINESS & TECHNOLOGY PARK
CARRIGTWOHILL, CO., CORK T45 HX08
IE

Ownership History

Cerus Endovascular Ltd.

Original Applicant
99
Oxford

Cerus Endovascular Ltd.

Owner at Publication
99
Oxford GB

Cerus Endovascular Ltd.

Original Registrant
99
Oxford GB

STRYKER IRELAND TECHNOLOGY LTD.

New Owner After Registration #1
16
CARRIGTWOHILL, CO., CORK IE

Legal Representation

Attorney
S. Peter Ludwig

USPTO Deadlines

Next Deadline
854 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-07)
Due Date
December 07, 2027
Grace Period Ends
June 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jun 20, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 7, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 3, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 2, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 14, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 12, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 30, 2021 IUAF S USE AMENDMENT FILED Loading...
Sep 30, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 6, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 6, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 6, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 6, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 5, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 4, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 4, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 4, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 28, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 5, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 21, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Medical devices for endovascular occlusion, treatment of vascular abnormalities, and for embolization, namely, endovascular devices that conform to vessel walls and promote clot formation in neurovascular and peripheral vascular structures, medical devices for treatment of aneurysms and vascular disease and for peripheral vascular embolization
First Use Anywhere: Aug 5, 2021
First Use in Commerce: Aug 5, 2021

Classification

International Classes
010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NEUROVASCULAR SYSTEM"